FDA Drug Application (020119) for VUMON by HQ SPECLT PHARMA

Back to FDA Applications sponsored by HQ SPECLT PHARMA

Application Number020119
Product Number001
FormINJECTABLE;INJECTION
Dosage10MG/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameVUMON
Active IngredientTENIPOSIDE



Back to FDA Applications sponsored by HQ SPECLT PHARMA